The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.50
Bid: 29.00
Ask: 30.00
Change: -0.50 (-1.67%)
Spread: 1.00 (3.448%)
Open: 29.50
High: 29.50
Low: 29.50
Prev. Close: 30.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results of GM, Open Offer and Total Voting Rights

28 Jul 2021 13:14

RNS Number : 7926G
Ilika plc
28 July 2021
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE.

 

 

Ilika Plc

 

Results of General Meeting, Open Offer and Total Voting Rights

 

On 9 July 2021, Ilika plc (AIM: IKA) the advanced solid-state battery company ("Ilika" or the "Company"), announced a conditional placing (the "Placing") to raise gross proceeds of approximately £18.0 million, a retail offer via PrimaryBid (the "Retail Offer") to raise gross proceeds of approximately £3.0 million and an associated open offer (the "Open Offer") to raise gross proceeds of up to approximately £3.7 million (the "Launch Announcement").

 

The Company is pleased to announce that, at its General Meeting held earlier today, all of the Resolutions set out in the circular dated 12 July 2021 were duly passed.

 

Further to this, the Company can now confirm that it will issue, pursuant to the Placing, the Retail Offer, the Open Offer and the Director Subscriptions, 17,673,809 New Ordinary Shares at 140 pence per share, raising approximately £24.7 million in aggregate. The issue of New Ordinary Shares will be split as follows:

 

· 12,846,428 shares under the Placing, raising gross proceeds of approximately £18.0 million;

· 2,142,857 shares under the Retail Offer, raising gross proceeds of approximately £3.0 million;

· 2,673,811 shares taken up under the Open Offer, including excess applications, raising gross proceeds of approximately £3.7 million; and

· 10,713 shares under the Director Subscriptions.

 

Under the Open Offer, the Company has received valid acceptances from Qualifying Shareholders in respect of their basic Open Offer Entitlements for 828,483 New Ordinary Shares, representing approximately 31 per cent. of the total Open Offer Shares available to Qualifying Shareholders. In addition, the Company has received valid applications from Qualifying Shareholders under the Excess Application Facility in respect of 1,984,741 New Ordinary Shares.

Qualifying Shareholders who have validly applied for Open Offer Shares will receive their full Open Offer Entitlement.

As applications under the Excess Application Facility cannot be satisfied in full, applications for New Ordinary Shares under the Excess Application Facility will be scaled back on the following basis: Applications under the Excess Application Facility for Excess Shares have been allocated approximately 92.98 per cent. of the number of Excess Shares applied for.

Accordingly, pursuant to the EIS/VCT Placing, the Company has applied to the London Stock Exchange for 1,428,571 New Ordinary Shares to be admitted to trading on AIM ("EIS/VCT Admission"). It is expected that EIS/VCT Admission will occur at 8.00 a.m. on 29 July 2021. Additionally, pursuant to the General Placing, the Retail Offer, the Open Offer and the Director Subscriptions, the Company has applied to the London Stock Exchange for 16,245,238 New Ordinary Shares to be admitted to trading on AIM ("General Admission"). It is expected that General Admission will occur at 8:00 a.m. on 30 July 2021.

 

Following EIS/VCT Admission and General Admission, the Company's issued share capital will comprise 156,711,981 ordinary shares of one penny each and that number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury.

 

As mentioned in the Launch Announcement, in addition, Steve Boydell, Brian Hayden and Graeme Purdy intend to exercise options entitling them to 10,000, 8,000 and 30,000 new Ordinary Shares respectively in accordance with the terms of the Company's bonus scheme as soon as reasonably practicable, conditionally on the Capital Raising becoming unconditional.

 

Capitalised terms not defined in this announcement have the meanings given to them in the Launch Announcement.

 

Commenting on the results of the General Meeting and the Open Offer, Graeme Purdy, Chief Executive of Ilika, said:

 

"We are delighted with the support for the fund raising, including from both existing and new institutional shareholders, which has been fully subscribed, raising the maximum of £24.7m. We look forward to accelerating the development of our solid-state electric vehicle pouch cells through our Goliath programme and will update the market with further developments in due course."

 

 

For more information contact:

 

Ilika plc

 

 

 

www.ilika.com

Graeme Purdy, Chief Executive

Via Walbrook PR

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan, William Hall, Nikhil Varghese

 

 

 

Joh. Berenberg, Gossler & Co. KG

Tel: 020 3207 8700

Emily Morris, Detlir Elezi,

Alamgir Ahmed, Milo Bonser

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / Ilika@walbrookpr.com

Tom Cooper

Mob: 0797 122 1972

Lianne Cawthorne

Mob: 07584 391 303

Nick Rome

Mob: 07748 325 236

 

Note:

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU Regulation No. 596/2014) (as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018) (the "UK MAR"). Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain. If you have any queries on this, then please contact Steve Boydell, Finance Director of the Company (the person responsible for arranging the release of this announcement) on 0203 8011 1400.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUPGMUPGGPR
Date   Source Headline
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.